About 2.5mg Apixa Tablets
Unveiling the magnificent, new release - Apixa 2.5mg Tablets, a US FDA and CDSCO approved anticoagulant, highlighted for its astounding efficacy in stroke prevention and treatment of DVT and PE. In demand among healthcare professionals, these grand, yellow oval tablets are prescription-only and embossed for identification. Each tablet contains Apixaban, a direct factor Xa inhibitor. Suitable for adults, Apixa ensures superior protection against thromboembolic disorders. Strictly follow physician's advice regarding dosing and avoid abrupt discontinuation. Store below 30C, protected from light and moisture, to retain potency.
Broader Uses and Patient Suitability for Apixa 2.5mg Tablets
Apixa 2.5mg Tablets are primarily recommended for adults combating nonvalvular atrial fibrillation, but their magnificent efficacy extends to the treatment and prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE). Highlighted for use by patients at risk of thromboembolic disorders, Apixa is administered orally as a regular course, typically twice daily. The flexible yet controlled usage, as prescribed by a healthcare professional, ensures tailored therapy for those needing robust antithrombotic support.
Sample Access and Swift Supply of Apixa 2.5mg Tablets
Express shipping and reliable transportation options make Apixa 2.5mg Tablets widely accessible for suppliers, traders, and wholesalers in India. Stock is ready for prompt dispatch, with sample availability for verification. Payment terms are flexible, adapting to varied business needs, while the grand supply ability ensures demands are met efficiently. Packaging includes boxes of 30 tablets, with guaranteed product integrity during transit. Choose Apixa for quality-assured anticoagulant solutions delivered on schedule.
FAQ's of 2.5mg Apixa Tablets:
Q: How should Apixa 2.5mg Tablets be taken for best results?
A: Apixa 2.5mg Tablets must be taken orally, usually twice daily, strictly as prescribed by your physician. Do not discontinue or alter the dosage without medical guidance.
Q: What are the main benefits of using Apixa 2.5mg Tablets?
A: Apixa significantly reduces the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation, and effectively treats and prevents DVT and PE.
Q: When is Apixa 2.5mg Tablets indicated for use?
A: The tablets are indicated for adults needing prevention of stroke, systemic embolism, deep vein thrombosis, and pulmonary embolism, especially those with atrial fibrillation or thromboembolic disorders.
Q: Where are Apixa 2.5mg Tablets manufactured and approved?
A: Apixa 2.5mg Tablets originate in India and are approved by the US FDA and CDSCO, reflecting high safety and quality standards.
Q: What process should be followed if a dose is missed?
A: If you miss a dose, take it as soon as you remember, unless it is almost time for the next dose. In that case, skip the missed dose and resume your schedule. Never double the dose.
Q: Are there any known interactions or side effects with Apixa 2.5mg Tablets?
A: Yes, Apixa may interact with other anticoagulants, NSAIDs, and specific antibiotics. Common side effects include bleeding, bruising, and anemia. Review the leaflet and consult your physician for a full list.
Q: Who should avoid taking Apixa 2.5mg Tablets?
A: Individuals allergic to Apixaban or any of its excipients should avoid these tablets. Always inform your doctor about allergies or concurrent medications before starting treatment.